• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类组氨酰-tRNA 合成酶(HARS)基因中的功能丧失变体在体内具有神经毒性。

A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.

机构信息

Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

出版信息

Hum Mutat. 2013 Jan;34(1):191-9. doi: 10.1002/humu.22210. Epub 2012 Oct 11.

DOI:10.1002/humu.22210
PMID:22930593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3535524/
Abstract

Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed enzymes responsible for ligating amino acids to cognate tRNA molecules. Mutations in four genes encoding an ARS have been implicated in inherited peripheral neuropathy with an axonal pathology, suggesting that all ARS genes are relevant candidates for disease in patients with related phenotypes. Here, we present results from a mutation screen of the histidyl-tRNA synthetase (HARS) gene in a large cohort of patients with peripheral neuropathy. These efforts revealed a rare missense variant (c.410G>A/p.Arg137Gln) that resides at a highly conserved amino acid, represents a loss-of-function allele when evaluated in yeast complementation assays, and is toxic to neurons when expressed in a worm model. In addition to the patient with peripheral neuropathy, p.Arg137Gln HARS was detected in three individuals by genome-wide exome sequencing. These findings suggest that HARS is the fifth ARS locus associated with axonal peripheral neuropathy. Implications for identifying ARS alleles in human populations and assessing them for a role in neurodegenerative phenotypes are discussed.

摘要

氨酰-tRNA 合成酶(ARSs)是广泛表达的酶,负责将氨基酸连接到相应的 tRNA 分子上。四个编码 ARS 的基因的突变与具有轴突病理学的遗传性周围神经病有关,这表明所有 ARS 基因都是具有相关表型的患者疾病的相关候选基因。在这里,我们报告了对一组大的周围神经病患者的组氨酸-tRNA 合成酶(HARS)基因进行突变筛选的结果。这些努力发现了一种罕见的错义变体(c.410G>A/p.Arg137Gln),该变体位于高度保守的氨基酸上,当在酵母互补测定中进行评估时代表失活等位基因,并且在蠕虫模型中表达时对神经元有毒。除了患有周围神经病的患者外,通过全基因组外显子组测序在另外三个人中检测到 p.Arg137Gln HARS。这些发现表明 HARS 是与轴突周围神经病相关的第五个 ARS 基因座。讨论了在人类群体中识别 ARS 等位基因并评估它们在神经退行性表型中的作用的意义。

相似文献

1
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.人类组氨酰-tRNA 合成酶(HARS)基因中的功能丧失变体在体内具有神经毒性。
Hum Mutat. 2013 Jan;34(1):191-9. doi: 10.1002/humu.22210. Epub 2012 Oct 11.
2
Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.HARS基因的功能丧失突变会导致一系列遗传性周围神经病。
Brain. 2015 Aug;138(Pt 8):2161-72. doi: 10.1093/brain/awv158. Epub 2015 Jun 13.
3
Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy.组氨酰-tRNA 合成酶相关的底物相互作用缺陷导致显性轴索性周围神经病。
Hum Mutat. 2018 Mar;39(3):415-432. doi: 10.1002/humu.23380. Epub 2017 Dec 26.
4
Peripheral neuropathy and cognitive impairment associated with a novel monoallelic variant.新型单等位基因突变与周围神经病变和认知障碍相关。
Ann Clin Transl Neurol. 2019 May 24;6(6):1072-1080. doi: 10.1002/acn3.791. eCollection 2019 Jun.
5
A single Danio rerio hars gene encodes both cytoplasmic and mitochondrial histidyl-tRNA synthetases.单个斑马鱼hars基因编码细胞质和线粒体组氨酰-tRNA合成酶。
PLoS One. 2017 Sep 21;12(9):e0185317. doi: 10.1371/journal.pone.0185317. eCollection 2017.
6
Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish.与神经病变相关的组氨酰-tRNA合成酶变体在体外减弱蛋白质合成,并破坏斑马鱼发育过程中的轴突生长。
FEBS J. 2021 Jan;288(1):142-159. doi: 10.1111/febs.15449. Epub 2020 Jul 6.
7
Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome.线粒体组氨酰 tRNA 合成酶 HARS2 突变导致 Perrault 综合征的卵巢发育不良和感觉神经性耳聋。
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6543-8. doi: 10.1073/pnas.1103471108. Epub 2011 Apr 4.
8
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.患者外周神经病中赖氨酸 tRNA 合成酶功能丧失突变的复合杂合性。
Am J Hum Genet. 2010 Oct 8;87(4):560-6. doi: 10.1016/j.ajhg.2010.09.008.
9
To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.是否充电:神经病相关 tRNA 合成酶突变的机制见解。
Curr Opin Genet Dev. 2013 Jun;23(3):302-9. doi: 10.1016/j.gde.2013.02.002. Epub 2013 Mar 4.
10
Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.半胱氨酰-tRNA 合成酶突变导致一种多系统的隐性疾病,包括小头畸形、发育迟缓以及脆弱的头发和指甲。
Am J Hum Genet. 2019 Mar 7;104(3):520-529. doi: 10.1016/j.ajhg.2019.01.006. Epub 2019 Feb 26.

引用本文的文献

1
Interpreting ribosome dynamics during mRNA translation.解析mRNA翻译过程中的核糖体动力学
J Biol Chem. 2025 Jul 10;301(8):110469. doi: 10.1016/j.jbc.2025.110469.
2
tRNA synthetase activity is required for stress granule and P-body assembly.应激颗粒和P小体组装需要tRNA合成酶活性。
bioRxiv. 2025 Mar 13:2025.03.10.642431. doi: 10.1101/2025.03.10.642431.
3
From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.从用于研究夏科-马里-图思病的体内模型到体外生物工程化神经肌肉接头
J Tissue Eng. 2025 Mar 12;16:20417314241310508. doi: 10.1177/20417314241310508. eCollection 2025 Jan-Dec.
4
Transfer RNA supplementation rescues HARS deficiency in a humanized yeast model of Charcot-Marie-Tooth disease.在夏科-马里-图斯病的人源化酵母模型中,转运RNA补充可挽救HARS缺陷。
Nucleic Acids Res. 2024 Dec 11;52(22):14043-14060. doi: 10.1093/nar/gkae996.
5
Characterization of a novel heterozygous variant in the histidyl-tRNA synthetase gene associated with Charcot-Marie-Tooth disease type 2W.鉴定与 2W 型腓骨肌萎缩症相关的组氨酰-tRNA 合成酶基因中的一种新型杂合变异。
IUBMB Life. 2024 Dec;76(12):1125-1138. doi: 10.1002/iub.2918. Epub 2024 Oct 1.
6
Mechanisms and Delivery of tRNA Therapeutics.tRNA 治疗药物的作用机制与递送。
Chem Rev. 2024 Jun 26;124(12):7976-8008. doi: 10.1021/acs.chemrev.4c00142. Epub 2024 May 27.
7
Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D.HDAC6 基因缺失对 CMT2D 人源化小鼠模型没有影响。
J Peripher Nerv Syst. 2024 Jun;29(2):213-220. doi: 10.1111/jns.12623. Epub 2024 Mar 29.
8
Dominant mutations causing axonal Charcot-Marie-Tooth disease expand -associated diseases.导致轴索性夏科-马里-图思病的显性突变会引发相关疾病。
Brain Commun. 2024 Mar 8;6(2):fcae070. doi: 10.1093/braincomms/fcae070. eCollection 2024.
9
An Adapted GeneSwitch Toolkit for Comparable Cellular and Animal Models: A Proof of Concept in Modeling Charcot-Marie-Tooth Neuropathy.用于可比细胞和动物模型的改良 GeneSwitch 工具包:在模拟 Charcot-Marie-Tooth 神经病方面的概念验证。
Int J Mol Sci. 2023 Nov 9;24(22):16138. doi: 10.3390/ijms242216138.
10
A variant of the gene detected in the clinical exome: etiology of a peripheral neuropathy undiagnosed for 20 years.在临床外显子组中检测到的一种基因变体:一例长达20年未确诊的周围神经病变的病因
Adv Lab Med. 2020 May 19;1(4):20200033. doi: 10.1515/almed-2020-0033. eCollection 2020 Dec.

本文引用的文献

1
Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.伴有丘脑和脑干受累及高乳酸性的脑白质病“LTBL”,由 EARS2 突变引起。
Brain. 2012 May;135(Pt 5):1387-94. doi: 10.1093/brain/aws070. Epub 2012 Apr 4.
2
Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans.线粒体甲硫氨酰-tRNA 合成酶中的突变导致果蝇的神经退行性表型和人类的隐性共济失调(ARSAL)。
PLoS Biol. 2012;10(3):e1001288. doi: 10.1371/journal.pbio.1001288. Epub 2012 Mar 20.
3
Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.GARS 相关的夏科-马里-图什神经病突变体在不依赖野生型 GARS 水平的情况下对周围神经元有毒性。
PLoS Genet. 2011 Dec;7(12):e1002399. doi: 10.1371/journal.pgen.1002399. Epub 2011 Dec 1.
4
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).2N 型腓骨肌萎缩症(CMT2N)患者中存在一种复发性丙氨酰-tRNA 合成酶(AARS)功能丧失突变。
Hum Mutat. 2012 Jan;33(1):244-53. doi: 10.1002/humu.21635. Epub 2011 Nov 9.
5
Clan genomics and the complex architecture of human disease.族基因组学与人类疾病的复杂结构。
Cell. 2011 Sep 30;147(1):32-43. doi: 10.1016/j.cell.2011.09.008.
6
Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.分散在单一蛋白质上的致病变异促进相同的局部构象打开。
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12307-12. doi: 10.1073/pnas.1104293108. Epub 2011 Jul 7.
7
Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy.外显子组测序鉴定婴儿期线粒体心肌病中线粒体丙氨酰-tRNA 合成酶突变。
Am J Hum Genet. 2011 May 13;88(5):635-42. doi: 10.1016/j.ajhg.2011.04.006. Epub 2011 May 5.
8
Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome.线粒体组氨酰 tRNA 合成酶 HARS2 突变导致 Perrault 综合征的卵巢发育不良和感觉神经性耳聋。
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6543-8. doi: 10.1073/pnas.1103471108. Epub 2011 Apr 4.
9
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.线粒体丝氨酰-tRNA 合成酶突变导致婴儿期高尿酸血症、肺动脉高压、肾衰竭和碱中毒,HUPRA 综合征。
Am J Hum Genet. 2011 Feb 11;88(2):193-200. doi: 10.1016/j.ajhg.2010.12.010. Epub 2011 Jan 20.
10
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.患者外周神经病中赖氨酸 tRNA 合成酶功能丧失突变的复合杂合性。
Am J Hum Genet. 2010 Oct 8;87(4):560-6. doi: 10.1016/j.ajhg.2010.09.008.